Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India

NCT ID: NCT05994820

Last Updated: 2024-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2058 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-26

Study Completion Date

2024-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn compare the efficacy Chatbot messaging directed to parents of infants and children living in unstable urban housing (UUH) in Varansi, India. The main questions it aims to answer are: 1) Can a Chatbot intervention be used to improve attitudes towards childhood vaccines? 2) Does an intervention in which vaccination is presented in the larger context of well-being improve attitudes towards vaccination?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Only 2/3 of Indian infants and children are fully immunized. In communities facing unstable urban housing (UUH) vaccination rates are even lower. COVID-19 introduced new challenges for community health workers in these areas, and many do not have the capacity to promote vaccination. At the same time, the pandemic also prompted more parents and caregivers to engage with smartphones to manage the child's health. The investigators believe that a WhatsApp-based Chatbot intervention may be an effective way to promote routine childhood vaccination among caregivers without creating additional burdens on community health workers. To test this, the investigators are developing the Happy Baby Programme. This programme will be disseminated as a Chatbot through WhatsApp to parents of infants and young children living in Varanasi, in the Indian state of Uttar Pradesh. In addition to testing the overall efficacy of a Chatbot messaging platform, the investigators will compare two different Chatbot messaging designs, one featuring vaccine-only messaging and a second that positions vaccines as part of a broader set of well-being practices.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Hesitancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

All parties are aware of assignment

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

These participants receive no intervention. No chatbot messaging. Usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Vaccine Campaign

These participants will receive the Happy Baby Programme messages through a WhatsApp Chatbot. All messages will be narrowly focused on vaccine promotion.

Group Type EXPERIMENTAL

Happy Baby Programme -Vaccine Campaign

Intervention Type BEHAVIORAL

The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi.

Vaccine++ Campaign

These participants will receive the Happy Baby Programme messages through a WhatsApp Chatbot. All messages will promote vaccines in conjunction with other health-promotion activities (e.g. nutrition, breastfeeding, etc.).

Group Type EXPERIMENTAL

Happy Baby Programme- Vaccine ++ Campaign

Intervention Type BEHAVIORAL

The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi as part of a holistic healthy baby approach that includes nutrition and sanitation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Happy Baby Programme -Vaccine Campaign

The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi.

Intervention Type BEHAVIORAL

Happy Baby Programme- Vaccine ++ Campaign

The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi as part of a holistic healthy baby approach that includes nutrition and sanitation.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Speak Hindi;
* Reside in selected UUH neighborhood of Varanasi, India;
* Identify as a caregiver of a young child (\<2) OR be at least 5 months pregnant and due to giver birth during the study period;
* Child is registered with local community health workers and included on patient rosters for vaccination clinics (also known as Village Health Sanitation and Nutrition Days (VHSNDs));
* Have regular access to a phone with WhatsApp.

Exclusion Criteria

* Only one caregiver is eligible per household
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johns Hopkins Bloomberg School of Public Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rajiv N Rimal, PhD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

D-COR (Development Corner) Consulting

Dwārka, New Delhi, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00023512

Identifier Type: OTHER

Identifier Source: secondary_id

IRB00023512

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hepatitis B Vaccination in Infants
NCT01896596 COMPLETED PHASE4
Persistence of IPV Immunity
NCT03723837 COMPLETED PHASE4